uMotif, ClinOne: unified eCOA/ePRO/eConsent
The two companies have partnered in an effort to delivery a single, integrated solution with an intuitive interface that provides improved eCOA, ePRO, and eConsent technology. The combined offering is intended to be cost-accessible, fast to deploy, and easy for participants to use on their own mobile devices.
“It is encouraging and refreshing to see so many sponsors and CROs adopt patient-first technologies like eCOA, ePRO (patient reported outcomes) and eConsent, but too often they are frustrated by disjointed solutions that place a high burden on users and limit effectiveness,” said Steve Rosenberg, CEO of uMotif. “Together, uMotif and ClinOne are setting out to directly address these pain points with a seamless and comprehensive solution that trial participants actually want to use. In this way, we will add immediate value to increase data quality and reduce risk while improving convenience and comfort for everyone involved with the trial.”
